A roundtable, held jointly between the Academy of Medical Sciences, the Medical Research Council and the National Institute for Health Research brought together experts from across the life sciences sectors to explore the challenges, opportunities and priorities for research and development of AI-driven technologies to ensure the benefits of AI in health can be fully achieved.
As AI continues to expand within the healthcare sector, the Academy’s roundtable provided a much-needed opportunity for members of the AI community, including experts from academia and industry, to come together with the NHS and funding bodies in an intimate, solution-focussed setting to identify priorities that will lead to future advantages for patients and the public.
One such priority calls on research funders to work with the wider UK community – including academia, industry, the NHS, public and private funders, regulators, patients and the public – to set out and deliver key research areas for AI and health. The meeting provided an important catalytic platform, acting as a starting point for innovative conversations that could lead to future collaborative work. If the UK is to remain a world-leader in AI health research, the sector must now take these initial discussions forward with this wider group of stakeholders.